InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: XenaLives post# 44865

Wednesday, 12/16/2015 10:37:59 PM

Wednesday, December 16, 2015 10:37:59 PM

Post# of 461943
Good thinking Xenalives....I was thinking along similar lines and yes could be Takeda or Otsuko (both into the dementia market and even have some knowledge with sigma 1 receptor science..... The other possibility offshore I was thinking could be a deal with a Germain company for Western European rights..... IMO also these deals do not have to be much more than selling exclusive marketing rights for their markets.... IMO with science results thus far, either of these two markets distribution rights . could be sold for sufficient funds to finance a P3 trial ... and in my opinion AVXL can retain full control of the 273 in AD world wide except they would be committed using them as a distributor only , in their defined market (or expanded as negotiated)..... I think Missling will get us a good deal....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News